Melrose outlines Garden Grove restart plan: Melrose Industries stock gains 2.72 percent
Published on 10/27/2026 at 12:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGarden Grove liability and margins
- Melrose disclosed up to USD 100 million in Garden Grove claims on October 13, 2026.
- First-half 2026 revenue reached GBP 1,873 million, while net income fell to GBP 75 million.
- Melrose Industries stock trades at EUR 5.66 at 12:37 p.m. CEST at Lang & Schwarz on October 27, 2026, 2.72 percent above the Xetra close of October 23, 2026.
Melrose Industries (ISIN GB00BNGDN821) is trading at EUR 5.66 at Lang & Schwarz on October 27, 2026, up 2.72 percent versus the Xetra close of October 23, 2026 at EUR 5.51. The central company event is the planned resolution of the Garden Grove investigation and a phased return to full production in the fourth quarter, outlined by Investegate on October 13, 2026.
Garden Grove carries a USD 100 million claim program
The agreement structure allocates up to USD 100 million to eligible residents and businesses, alongside USD 15 million in civil enforcement penalties and USD 10 million in emergency-service claims. Court approval remains part of the process, while Melrose said the site could return to full capacity in phases during the fourth quarter.
The facility generated GBP 136 million in sales during fiscal year 2025, giving the restart a measurable revenue connection. The company also said the associated insurance position was under review, which leaves the final economic effect dependent on the claims process.
What do the margins mean for investors?
Melrose's first-half 2026 revenue rose to GBP 1,873 million from GBP 1,720 million, but net income dropped to GBP 75 million from GBP 285 million. These figures, reported by Simply Wall St, show that the 8.90 percent revenue increase did not translate into higher earnings. Net margin fell from 16.60 percent to 4.00 percent during the same period.
Three milestones define the timeline
On July 31, 2026, Melrose reported first-half revenue of GBP 1,873 million. On October 13, 2026, it outlined the Garden Grove resolution, including up to USD 100 million in claims. On October 27, 2026, the Lang & Schwarz quote stood at EUR 5.66, versus the dated Xetra close of EUR 5.51.
Which dates come next?
Melrose's next trading update for the four months through October 31, 2026, is scheduled for November 18, 2026, according to Investegate. Fiscal year 2026 results are listed for February 26, 2027, by Simply Wall St.
Analysts still see a wide valuation gap
RBC Capital maintained a Buy rating and set a GBp 800.00 target on October 9, 2026, according to Business Insider. That target is a separate London-market reference and does not replace the euro quote used here.
Stock price and company profile
Melrose was trading at EUR 5.66 at Lang & Schwarz on October 27, 2026 at 12:37 p.m. CEST, 2.72 percent above the Xetra close of October 23, 2026 at EUR 5.51. The further course of trading is shown by the continuously updated real-time quote of Melrose Industries stock.
Melrose Industries at a glance
- Company: Melrose Industries PLC
- ISIN: GB00BNGDN821
- Ticker: MRO
- Primary exchange: LSE
- Price Lang & Schwarz as of October 27, 2026, 12:37 p.m. CEST: EUR 5.66
- Change versus Xetra close: plus 2.72 percent
- Xetra close October 23, 2026: EUR 5.51
- Market capitalization: GBP 5.8 billion as of October 27, 2026
- 52-week range: GBp 409.90-685.00 as of October 27, 2026
- Sector / Industry: Industrials / Aerospace and Defense
- Index membership: FTSE 100
- Next earnings date: February 26, 2027
Market context: Market report FTSE 100.
